AxoGen, Inc. (AXGN) financial statements and ratios from SEC XBRL: revenue $225.21M (TTM), net margin -7.0%, revenue growth 23.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $225.21M |
| Net Margin | -7.0% |
| Revenue Growth (YoY) | 23.1% |
| EPS Growth (YoY) | -400.0% |
| FCF Growth (YoY) | -9.7% |
| Price / Book | 9.74 |
| Price / Sales | 9.94 |
| FCF Yield | 0.3% |
| Altman Z-Score | 15.06 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
AXGN overview · AXGN earnings · AXGN KPIs · AXGN investor relations · AXGN ownership · AXGN peers · AXGN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.